#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3883092	F	Agonist activity at human recombinant EP3A receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay	Homo sapiens	114		cell-based format	Patent Bioactivity Data
2.	ALA3883093	B	Displacement of [3H]PGE2 from from human EP2 receptor expressed in HEK293 cells at pH 7.3 membranes incubated for 60 mins	Homo sapiens	55		cell-based format	Patent Bioactivity Data
3.	ALA3883096	F	Agonist activity at human recombinant FP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay	Homo sapiens	96		cell-based format	Patent Bioactivity Data
4.	ALA3883097	F	Agonist activity at human recombinant EP1 receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay	Homo sapiens	95		cell-based format	Patent Bioactivity Data
5.	ALA3883098	F	Agonist activity at human recombinant EP2 receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay	Homo sapiens	140		cell-based format	Patent Bioactivity Data
6.	ALA3883100	F	Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay	Homo sapiens	114		cell-based format	Patent Bioactivity Data
7.	ALA3883101	F	Agonist activity at human recombinant IP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay	Homo sapiens	114		cell-based format	Patent Bioactivity Data
8.	ALA3883102	F	Agonist activity at human recombinant DP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay	Homo sapiens	112		cell-based format	Patent Bioactivity Data
9.	ALA3883113	F	Reduction in intraocular pressure in Beagle dog assessed as maximal change in intraocular pressure at 0.3% administered topically to one eye immediately after first intraocular pressure reading by pneumatonometry	Canis lupus familiaris	3		tissue-based format	Patent Bioactivity Data
10.	ALA3883114	F	Effect on ocular surface hyperemia in Beagle dog assessed as maximum ocular surface hyperemia score assigned value at 0.3% administered topically to one eye immediately after first intraocular pressure reading by pneumatonometry	Canis lupus familiaris	3		tissue-based format	Patent Bioactivity Data